Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 701–800 of 1,004

A double‐blind, placebo‐controlled study of naltrexone in the treatment of alcohol dependence in Taiwan
Huang, M., Chen, C.-Y. O., Yu, J., & Chen, C. (2005) · Addiction Biology · doi:10.1080/13556210500223504 · Cited by 39
Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection
Williams, K. L., & Broadbridge, C. L. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.11.003 · Cited by 39
Advances in Animal Models of Relapse for Addiction Research
Weiss, F. (2010) · Frontiers in neuroscience · doi:10.1201/9781420007350-c1 · Cited by 40
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study
Quelch, D. R., Mick, I., McGonigle, J., Ramos, A. C., Flechais, R., Bolstridge, M., Rabiner, E. A., Wall, M. B., Newbould, R. D., Steiniger‐Brach, B., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.029 · Cited by 41
PRECLINICAL STUDY: Schedule‐induced alcohol drinking: non‐selective effects of acamprosate and naltrexone
Escher, T., & Mittleman, G. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00004.x · Cited by 39
Physicochemical Evaluation, in Vitro Human Skin Diffusion, and Concurrent Biotransformation of 3-O-Alkyl Carbonate Prodrugs of Naltrexone
Pillai, O., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033000.03652.73 · Cited by 39
Recent advances in the psychotherapy of addictive disorders
Carroll, K. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0032-5 · Cited by 40
Neuropeptides: implications for alcoholism
Cowen, M. S., Chen, F., & Lawrence, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02394.x · Cited by 39
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 43
Long-Term Therapy using GHB (Sodium Gamma Hydroxybutyrate) for Treatment-Resistant Chronic Alcoholics
Marremmani, I., Lamanna, F., & Tagliamonte, A. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400478 · Cited by 39
SHORT-TERM METHADONE ADMINISTRATION REDUCES ALCOHOL CONSUMPTION IN NON-ALCOHOLIC HEROIN ADDICTS
Caputo, F. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.2.164 · Cited by 39
Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism
Hernández–Ávila, C. A., Oncken, C. A., Kirk, J. V., Wand, G. S., & Kranzler, H. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01334-8 · Cited by 39
Differential effects of μ and κ opioid antagonists on Fos-like immunoreactivity in extended amygdala
Carr, K. D., Kutchukhidze, N., & Park, T. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01088-4 · Cited by 39
Combination of Naltrexone and Fluoxetine on Rats?? Propensity to Take Alcoholic Beverage
Gardell, L. R., Whalen, C. A., Chattophadyay, S., Cavallaro, C. A., Hubbell, C. L., & Reid, L. D. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199711000-00013 · Cited by 39
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment‐Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of Varenicline
Miranda, R., O’Malley, S. S., Padovano, H. T., Wu, R., Falk, D. E., Ryan, M. L., Fertig, J. B., Chun, T. H., Muvvala, S. B., & Litten, R. Z. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14352 · Cited by 37
Pharmacologic Dissociation Between Impulsivity and Alcohol Drinking in High Alcohol Preferring Mice
Oberlin, B. G., Bristow, R. E., Heighton, M. E., & Grahame, N. J. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01220.x · Cited by 39
Effects of naltrexone plus topiramate on ethanol self‐administration and tyrosine hydroxylase gene expression changes
Navarrete, F., Rubio, G., & Manzanares, J. (2013) · Addiction Biology · doi:10.1111/adb.12058 · Cited by 38
An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence
Johnson, B. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1943 · Cited by 38
Gene Transcription Alterations Associated with Decrease of Ethanol Intake Induced by Naltrexone in the Brain of Wistar Rats
Oliva, J. M., & Manzanares, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301237 · Cited by 38
What Place Does Naltrexone Have in the Treatment of Alcoholism?
Rohsenow, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418090-00001 · Cited by 38
Opiate antagonists in children and adolescents
Chabane, N., Leboyer, M., & Mouren, M. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070018 · Cited by 38
Further evidence that naloxone acts as an inverse opiate agonist: Implications for drug dependence and withdrawaL
Cruz, S. L., Villarreal, J. E., & Volkow, N. D. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00250-0 · Cited by 38
Naltrexone Augmentation of Neuroleptics in Schizophrenia
Sernyak, M. J., Glazer, W. M., Heninger, G. R., Charney, D. S., Woods, S. W., Petrakis, I. L., Krystal, J. H., & Price, L. H. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00011 · Cited by 38
The Effects of Naloxone on Expression and Acquisition of Ethanol Place Conditioning in Rats
Bormann, N. M., & Cunningham, C. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00304-3 · Cited by 38
Naltrexone pretreatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food under concurrent progressive-ratio schedules in rhesus monkeys
Rodefer, J. S., Campbell, U. C., Cosgrove, K., & Carroll, M. E. (1999) · Psychopharmacology · doi:10.1007/s002130050854 · Cited by 38
Use of Acamprosate and Opioid Antagonists in the Treatment of Alcohol Dependence: A European Perspective
Soyka, M., & Chick, J. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00497.x · Cited by 37
Liver transplantation in patients with alcohol and other substance use disorders
DiMartini, A. F., Weinrieb, R. M., & Fireman, M. (2002) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00058-3 · Cited by 38
Endogenous opioids implicated in the dynamics of experimental drug addiction: an in vivo autoradiographic analysis
Gerrits, M. A. F. M., Wiegant, V. M., & van Ree, J. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00336-4 · Cited by 38
Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone
Ahmadi, J., Ashkani, H., Ahmadi, M., & Ahmadi, N. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00027-8 · Cited by 37
Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6β-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents
Hamad, M. O., Kiptoo, P. K., Stinchcomb, A. L., & Crooks, P. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.018 · Cited by 37
Naltrexone Improves Quit Rates, Attenuates Smoking Urge, and Reduces Alcohol Use in Heavy Drinking Smokers Attempting to Quit Smoking
Fridberg, D. J., Cao, D., Grant, J. E., & King, A. C. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12513 · Cited by 37
Neurobiology of drug addiction.
Koob, G. F., Caine, S. B., Hyytiä, P., Markou, A., Parsons, L. H., Roberts, A. J., Schulteis, G., & Weiss, F. (1999) · American Psychological Association eBooks · doi:10.1037/10341-008 · Cited by 38
Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial
Mann, K. F., Ackermann, K., Diehl, A., Ebert, D., Mundle, G., Nakovics, H., Reker, T., Richter, G., Schmidt, L., Drießen, M., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0243-9 · Cited by 36
Kleptomania After Head Trauma
Aizer, A., Lowengrub, K., & Dannon, P. N. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000144042.66342.d3 · Cited by 37
Bridging the gap between alcoholism treatment research and practice: Identifying what works and why.
Read, J. P., Kahler, C. W., & Stevenson, J. F. (2001) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.32.3.227 · Cited by 37
Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers
Roche, D. J. O., Ray, L. A., Yardley, M. M., & King, A. C. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0081-3 · Cited by 39
How treatments for pathological gambling can be informed by treatments for substance use disorders.
Petry, N. M. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.3.184 · Cited by 37
Competing motivations: drug reinforcement vs non-drug reinforcement
Bigelow, G. E., Brooner, R. K., & Silverman, K. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200102 · Cited by 37
Using fuzzy logic to predict response to citalopram in alcohol dependence
Naranjo, C. A., Bremner, K. E., Bazoon, M., & Turksen, I. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90070-9 · Cited by 37
In Vitro/in Vivo Correlation of Transdermal Naltrexone Prodrugs in Hairless Guinea Pigs
Valiveti, S., Paudel, K. S., Hammell, D. C., Hamad, M. O., Chen, J., Crooks, P. A., & Stinchcomb, A. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4593-0 · Cited by 37
Determination of Naltrexone and 6- -Naltrexol in Plasma by Solid-Phase Extraction and Gas Chromatography-Negative Ion Chemical Ionization-Mass Spectrometry
Huang, W., Moody, D. E., Foltz, R. L., & WALSH, S. L. (1997) · Journal of Analytical Toxicology · doi:10.1093/jat/21.4.252 · Cited by 36
Naltrexone Persistently Reduces Rats' Intake of a Palatable Alcoholic Beverage
Gardell, L. R., Hubbell, C. L., & Reid, L. D. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01097.x · Cited by 37
Cognitive behavioral therapy delays relapse in female socially phobic alcoholics
Thevos, A. K., Roberts, J. S., Thomas, S. E., & Randall, C. L. (2000) · Addictive Behaviors · doi:10.1016/s0306-4603(99)00067-2 · Cited by 35
Chronic Ethanol Consumption Reduces δ‐and μ‐Opioid Receptor–Stimulated G‐Protein Coupling in Rat Brain
Saland, L. C., Abeyta, A., Frausto, S. F., Raymond‐Stintz, M. A., Hastings, C. M., Carta, M., Valenzuela, C. F., & Savage, D. D. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000108658.00243.bf · Cited by 36
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
Rohsenow, D. J., Miranda, R., McGeary, J. E., & Monti, P. M. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.3.272 · Cited by 36
Polymorphisms in the µ-Opioid Receptor Gene ( OPRM1 ) and the Implications for Alcohol Dependence in Humans
van der Zwaluw, C. S., Wildenberg, E. V. D., Wiers, R. W. H. J., Franke, B., Buitelaar, J. K., Scholte, R. H. J., & Engels, R. C. M. E. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.10.1427 · Cited by 35
The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.
Reid, S., Teesson, M., Sannibale, C., Matsuda, M., & Haber, P. (2005) · Journal of Studies on Alcohol · doi:10.15288/jsa.2005.66.833 · Cited by 36
Treatment of addictive behaviors in liver transplant patients
Weinrieb, R. M., & Lucey, M. R. (2007) · Liver Transplantation · doi:10.1002/lt.21340 · Cited by 36
Transdermal Delivery of Naltrexone and its Active Metabolite 6-β-Naltrexol in Human Skin in Vitro and Guinea Pigs in Vivo
Paudel, K. S., Nalluri, B. N., Hammell, D. C., Valiveti, S., Kiptoo, P. K., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20398 · Cited by 36
Linkage with Primary Medical Care in a Prospective Cohort of Adults with Addictions in Inpatient Detoxification: Room for Improvement
Saitz, R., Larson, M. J., Horton, N. J., Winter, M. R., & Samet, J. H. (2004) · Health Services Research · doi:10.1111/j.1475-6773.2004.00246.x · Cited by 36
The Opioidergic-Alcohol Link
Modesto‐Lowe, V., & Fritz, E. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519080-00005 · Cited by 36
Periodic Naltrexone and Propensity To Take Alcoholic Beverage
Reid, L. D., Gardell, L. R., Chattopadhyay, S., & Hubbell, C. L. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01130.x · Cited by 36
Issues in the selection and development of therapies in alcoholism treatment matching research.
Donovan, D. M., Kadden, R. M., DiClemente, C. C., Carroll, K. M., Longabaugh, R., Zweben, A., & Rychtarik, R. G. (1994) · Journal of Studies on Alcohol Supplement · doi:10.15288/jsas.1994.s12.138 · Cited by 36
The delta opioid receptor antagonist, SoRI‐9409, decreases yohimbine stress‐induced reinstatement of ethanol‐seeking
Nielsen, C. K., Simms, J. A., Bito‐Onon, J. J., Li, R., Ananthan, S., & Bartlett, S. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00295.x · Cited by 36
Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence
Wu, J., Gao, M., & Taylor, D. H. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.181 · Cited by 35
Matching patients with substance use disorder to optimal level of care with the ASAM Criteria software
Stallvik, M., Gastfriend, D. R., & Nordahl, H. M. (2014) · Journal of Substance Use · doi:10.3109/14659891.2014.934305 · Cited by 35
Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study
Ray, L. A., & Oslin, D. W. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.006 · Cited by 35
Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model
Pickens, C. L., Cifani, C., Navarre, B. M., Eichenbaum, H., Theberge, F. R. M., Baumann, M. H., Calu, D. J., & Shaham, Y. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2585-9 · Cited by 36
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat
Häggkvist, J., Lindholm, S., & Franck, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.021 · Cited by 35
Abstinence From Drugs of Abuse in Community-Based Members of Narcotics Anonymous
Galanter, M. S., Dermatis, H., Post, S. G., & Santucci, C. (2013) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2013.74.349 · Cited by 35
Human Skin Permeation of Branched-Chain 3-O-Alkyl Ester and Carbonate Prodrugs of Naltrexone
Vaddi, H. K., Hamad, M. O., Chen, J., Banks, S. L., Crooks, P. A., & Stinchcomb, A. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2592-9 · Cited by 35
A duplex “Gemini” prodrug of naltrexone for transdermal delivery
Hammell, D. C., Hamad, M. O., Vaddi, H. K., Crooks, P. A., & Stinchcomb, A. L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.020 · Cited by 35
SUBSTANCE ABUSE AND EMERGENCY PSYCHIATRY
Zealberg, J. J., & Brady, K. T. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70127-1 · Cited by 35
Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone
Gerrits, M. A. F. M., Kuzmin, A. V., & van Ree, J. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.11.004 · Cited by 35
Ablation of μ opioid receptor-expressing GABA neurons in rostromedial tegmental nucleus increases ethanol consumption and regulates ethanol-related behaviors
Fu, R., Chen, X., Zuo, W., Li, J., Kang, S., Zhou, L.-H., Siegel, A., Bekker, A., & Ye, J.-H. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.027 · Cited by 35
Development of medications for alcohol use disorders: recent advances and ongoing challenges
Litten, R. Z., Fertig, J. B., Mattson, M. E., & Egli, M. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.323 · Cited by 36
Development of Novel Pharmacotherapies for the Treatment of Alcohol Dependence: Focus on Antiepileptics
Johnson, B. A., Swift, R. M., Ait‐Daoud, N., DiClemente, C. C., Javors, M. A., & Malcolm, R. J. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000113409.47937.6c · Cited by 35
Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: immunohistochemical analysis with quantitiative confocal microscopy
Saland, L. C., Hastings, C. M., Abeyta, A., & Chavez, J. B. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.02.016 · Cited by 35
Effect of Ethanol Drinking on the Gene Expression of Opioid Receptors, Enkephalinase, and Angiotensin‐Converting Enzyme in Two Inbred Mice Strains
Winkler, A., Búzás, B., Siems, W., Heder, G., & Cox, B. M. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03907.x · Cited by 35
Recognition and Treatment of Late-Life Addictions in Medical Settings
Stewart, D., & Oslin, D. W. (2001) · Journal of Clinical Geropsychology · doi:10.1023/a:1009589706810 · Cited by 34
The Physician's Role in Caring for Patients with Substance use Disorders: Implications for Medical Education and Training
Fiellin, D. A., Butler, R., D’Onofrio, G., Brown, R. L., & O’Connor, P. G. (2002) · Substance Abuse · doi:10.1080/08897070209511516 · Cited by 33
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs
Valiveti, S., Hammell, D. C., Paudel, K. S., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.005 · Cited by 34
A Perfect Platform: Combining Contingency Management with Medications for Drug Abuse
Carroll, K. M., & Rounsaville, B. J. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701301319 · Cited by 34
Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal
Göktalay, G., Çavun, S., Levendusky, M. C., Hamilton, J. R., & Millington, W. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.034 · Cited by 34
Presynaptic δ Opioid Receptors Regulate Ethanol Actions in Central Amygdala
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112722 · Cited by 35
Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens
Selleck, R. A., & Baldo, B. A. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4522-4 · Cited by 34
Determination of naltrexone and its major metabolite, 6-β-naltrexol, in human plasma using liquid chromatography with electrochemical detection
Davidson, A. F., Emm, T. A., & Pieniaszek, H. J. (1996) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(96)01794-3 · Cited by 34
COMPARISON OF CYANAMIDE AND PLACEBO IN THE TREATMENT OF ALCOHOL DEPENDENCE OF ADOLESCENTS
Niederhofer, H., Staffen, W., & Mair, A. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg011 · Cited by 34
Clinical Measurement of Craving in Addiction
Anton, R. F., & Drobes, D. J. (1998) · Psychiatric Annals · doi:10.3928/0048-5713-19981001-06 · Cited by 34
Pharmacological Relapse Prevention in Alcohol Dependence: From Animal Models to Clinical Trials
Boening, J., Lesch, O. M., Spanagel, R., Wolffgramm, J., Narita, M., Sinclair, D., Mason, B. J., & Wiesbeck, G. A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00022 · Cited by 34
Recommended Drug Treatment Strategies for the Alcoholic Patient
Schaffer, A., & Naranjo, C. A. (1998) · Drugs · doi:10.2165/00003495-199856040-00005 · Cited by 34
Endorphins and experimental addiction
van Ree, J. M. (1996) · Alcohol · doi:10.1016/0741-8329(95)02036-5 · Cited by 34
Influence of naltrexone on cue-elicited craving among hazardous drinkers: The moderational role of positive outcome expectancies.
Palfai, T. P., Davidson, D., & Swift, R. M. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.3.266 · Cited by 34
A Preliminary Investigation of the Management of Alcohol Dependence With Naltrexone by Primary Care Providers
O’Connor, P. G., Farren, C. K., Rounsaville, B. J., & O’Malley, S. S. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00271-4 · Cited by 34
Alcohol: A stimulant activating brain stress responsive systems with persistent neuroadaptation
Zhou, Y., & Kreek, M. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.044 · Cited by 34
Systematic review and meta-analysis of opioid antagonists for smoking cessation
David, S. P., Chu, I. M., Lancaster, T., Stead, L. F., Evins, A. E., & Prochaska, J. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004393 · Cited by 33
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Lohoff, F. W. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0079 · Cited by 37
Does Effect Size in Naltrexone Trials for Alcohol Dependence Differ for Single-Site vs. Multi-Center Studies?
Feinn, R., & Kranzler, H. R. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000171061.03686.bc · Cited by 32
Understanding attitudes toward use of medication in substance abuse treatment: A multilevel approach.
Fitzgerald, J., & McCarty, D. W. (2009) · Psychological Services · doi:10.1037/a0013420 · Cited by 33
An open clinical trial of naltrexone for amphetamine dependence: Compliance and tolerability
Jayaram‐Lindström, N., Wennberg, P., Beck, O., & Franck, J. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480510023052 · Cited by 33
The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders
Workgroup, T. A., Anton, R. F., Litten, R. Z., Falk, D. E., Palumbo, J., Bartus, R. T., Robinson, R. L., Kranzler, H. R., Kosten, T. R., Meyer, R. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.182 · Cited by 33
Reverse Selection for Differential Response to the Locomotor Stimulant Effects of Ethanol Provides Evidence for Pleiotropic Genetic Influence on Locomotor Response to Other Drugs of Abuse
Bergstrom, H. C., Palmer, A. A., Wood, R. D., Burkhart‐Kasch, S., McKinnon, C. S., & Phillips, T. J. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000091226.18969.b9 · Cited by 33
Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains.
Winkler, A., Buzás, B., Siems, W. ‐., Heder, G., & Cox, B. M. (1998) · PubMed · Cited by 33
Short of Complete Abstinence: An Analysis Exploration of Multiple Drinking Episodes in Alcoholism Treatment Trials
Wang, S., Winchell, C. J., McCormick, C. G., Nevius, S. E., & O’Neill, R. T. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02486.x · Cited by 33
THE MANAGEMENT OF TREATMENT RESISTANCE IN DEPRESSED PATIENTS WITH SUBSTANCE USE DISORDERS
Nunes, E. V., Deliyannides, D. A., Donovan, S. J., & McGrath, P. J. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70290-2 · Cited by 33
A comparison of the effects of 6-β naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats
Stromberg, M. F., Rukstalis, M. R., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00721-9 · Cited by 33
Self-citation
Dosing Issues in the Pharmacotherapy of Alcoholism
Mason, B. J. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01184.x · Cited by 33
Implantable technology for long-term delivery of nalmefene for treatment of alcoholism
Costantini, L. C., Kleppner, S. R., McDonough, J., Azar, M. R., & Patel, R. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.034 · Cited by 33
Naltrexone Treatment for Alcohol Dependence
Fuller, R. K., & Gordis, E. (2001) · New England Journal of Medicine · doi:10.1056/nejm200112133452411 · Cited by 33
The role of GABAA receptors in mediating the effects of alcohol in the central nervous system
Davies, M. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0333 · Cited by 325

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks